Literature DB >> 3489440

Comparative uptake of gentamicin, netilmicin, and amikacin in the guinea pig cochlea and vestibule.

D Dulon, J M Aran, G Zajic, J Schacht.   

Abstract

The kinetics of the entry of three aminoglycosides into inner-ear tissues of the guinea pig after acute and chronic administration were compared: gentamicin toxic to the cochlea and the vestibule, amikacin preferentially cochleotoxic, and netilmicin of low ototoxic liability. During constant intravenous infusion, levels of the three drugs in plasma tended to reach a plateau after 1 h, while levels in perilymph did not reach a plateau within 6 h. The drug concentrations in both vestibular and cochlear tissues quickly reached saturation. Amikacin and gentamicin concentrations were similar in vestibular and cochlear tissues, while netilmicin values were somewhat lower. After 1 week of chronic treatment (100 mg of drug per kg of body weight daily subcutaneously), levels of gentamicin and amikacin in tissue were similar to each other and were not significantly different between cochlear and vestibular tissues. Netilmicin concentrations again were somewhat lower in the tissues, but identical to those of the other drugs in the perilymph. After 3 weeks of treatment, all of the drugs were equally distributed in the inner-ear tissues. Release of the drug from the tissues after the 3-week treatment was faster for amikacin (83% decrease after 20 days) than for netilmicin and gentamicin (approximately 50% decrease). There was no correlation, under any of the experimental conditions, between the drug concentrations and their degrees of toxicity. These results demonstrate that selective aminoglycoside ototoxicity cannot be explained by a preferential uptake or accumulation of drugs in the afflicted tissues or in the perilymph.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489440      PMCID: PMC176443          DOI: 10.1128/AAC.30.1.96

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Comparative ototoxicity of amikacin and gentamicin in cats.

Authors:  E F Christensen; J C Reiffenstein; H Madissoo
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

3.  Distribution within the cochlea of dihydrostreptomycin injected into the circulation. An autoradiographic and electron microscopic study.

Authors:  M Portmann; J Darrouzet; Ch Coste
Journal:  Arch Otolaryngol       Date:  1974-12

4.  Ototoxicity of tobramycin, gentamicin, amikacin and sisomicin in the guinea pig.

Authors:  R E Brummett; K E Fox; T W Bendrick; D L Himes
Journal:  J Antimicrob Chemother       Date:  1978-05       Impact factor: 5.790

5.  Relationship between rat renal accumulation of gentamicin, tobramycin, and netilmicin and their nephrotoxicities.

Authors:  M E Brier; P R Mayer; R A Brier; D Visscher; F C Luft; G R Aronoff
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

6.  Neomycin concentrations in inner ear tissues and other organs of the guinea pig after chronic drug administration.

Authors:  C S Desrochers; J Schacht
Journal:  Acta Otolaryngol       Date:  1982       Impact factor: 1.494

7.  Comparative ototoxic liability of netilmicin and gentamicin.

Authors:  R E Brummett; K E Fox; R T Brown; D L Himes
Journal:  Arch Otolaryngol       Date:  1978-10

8.  Characterization of aminoglycoside-lipid interactions and development of a refined model for ototoxicity testing.

Authors:  B M Wang; N D Weiner; A Takada; J Schacht
Journal:  Biochem Pharmacol       Date:  1984-10-15       Impact factor: 5.858

9.  Low ototoxicity and its mechanism of netilmicin.

Authors:  I Ohtani; K Ohtsuki; T Aikawa; Y Sato; T Anzai; J Ouchi; T Saito
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1985       Impact factor: 1.538

10.  Gentamicin persistence in rat endolymph and perilymph after a two-day constant infusion.

Authors:  P Tran Ba Huy; A Meulemans; M Wassef; C Manuel; O Sterkers; C Amiel
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

View more
  17 in total

1.  A systemic gentamicin pathway across the stria vascularis.

Authors:  Chun Fu Dai; Peter S Steyger
Journal:  Hear Res       Date:  2007-11-17       Impact factor: 3.208

2.  Distribution of gentamicin in the guinea pig inner ear after local or systemic application.

Authors:  Shun-Ichi Imamura; Joe C Adams
Journal:  J Assoc Res Otolaryngol       Date:  2003-06

3.  Regeneration of cochlear efferent nerve terminals after gentamycin damage.

Authors:  A K Hennig; D A Cotanche
Journal:  J Neurosci       Date:  1998-05-01       Impact factor: 6.167

4.  Total extraction of aminoglycosides from guinea pig and bullfrog tissues with sodium hydroxide or trichloroacetic acid.

Authors:  K E Fox
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

Review 5.  Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.

Authors:  K Mörike; M Schwab; U Klotz
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

6.  Response of mechanosensory hair cells of the zebrafish lateral line to aminoglycosides reveals distinct cell death pathways.

Authors:  Kelly N Owens; Allison B Coffin; Lisa S Hong; Keri O'Connell Bennett; Edwin W Rubel; David W Raible
Journal:  Hear Res       Date:  2009-03-11       Impact factor: 3.208

7.  Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides.

Authors:  J M Gatell; F Ferran; V Araujo; M Bonet; E Soriano; J Traserra; J G SanMiguel
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

8.  Screen of FDA-approved drug library reveals compounds that protect hair cells from aminoglycosides and cisplatin.

Authors:  Anna L Vlasits; Julian A Simon; David W Raible; Edwin W Rubel; Kelly N Owens
Journal:  Hear Res       Date:  2012-08-31       Impact factor: 3.208

Review 9.  Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

Authors:  Jochen Schacht; Andra E Talaska; Leonard P Rybak
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

10.  Efficacy and tolerability of extended-interval aminoglycoside administration in pediatric patients.

Authors:  Donna M Kraus; Manjunath P Pai; Keith A Rodvold
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.